Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents
申请人:PFIZER INC.
公开号:US10662204B2
公开(公告)日:2020-05-26
Compounds of the general formula:
processes for the preparation of these compounds, compositions containing these compounds, and administration of these compounds to patients to treat pancreatic, lung, colon and other cancers.
SUBSTITUTED QUINAZOLINE AND PYRIDOPYRIMIDINE DERIVATIVES USEFUL AS ANTICANCER AGENTS
申请人:Pfizer Inc.
公开号:EP3746435B1
公开(公告)日:2022-08-03
Substituted Quinazoline and Pyridopyrimidine Derivatives Useful as Anticancer Agents
申请人:PFIZER INC.
公开号:US20190233440A1
公开(公告)日:2019-08-01
Compounds of the general formula:
processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.